Annual revenue:
$178.96M+$8.68M(+5.10%)Summary
- As of today (May 29, 2025), ADPT annual revenue is $178.96 million, with the most recent change of +$8.68 million (+5.10%) on December 31, 2024.
- During the last 3 years, ADPT annual revenue has risen by +$24.61 million (+15.95%).
- ADPT annual revenue is now -3.43% below its all-time high of $185.31 million, reached on December 31, 2022.
Performance
ADPT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$52.44M+$4.98M(+10.50%)Summary
- As of today (May 29, 2025), ADPT quarterly revenue is $52.44 million, with the most recent change of +$4.98 million (+10.50%) on March 31, 2025.
- Over the past year, ADPT quarterly revenue has increased by +$10.57 million (+25.24%).
- ADPT quarterly revenue is now -4.99% below its all-time high of $55.20 million, reached on December 31, 2022.
Performance
ADPT Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$189.53M+$10.57M(+5.91%)Summary
- As of today (May 29, 2025), ADPT TTM revenue is $189.53 million, with the most recent change of +$10.57 million (+5.91%) on March 31, 2025.
- Over the past year, ADPT TTM revenue has increased by +$15.03 million (+8.61%).
- ADPT TTM revenue is now -0.04% below its all-time high of $189.60 million, reached on June 30, 2023.
Performance
ADPT TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ADPT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.1% | +25.2% | +8.6% |
| 3 y3 years | +15.9% | +35.8% | +22.6% |
| 5 y5 years | +110.4% | +150.8% | +103.1% |
ADPT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.4% | +15.9% | -5.0% | +39.3% | -0.0% | +22.6% |
| 5 y | 5-year | -3.4% | +110.4% | -5.0% | +150.8% | -0.0% | +105.6% |
| alltime | all time | -3.4% | +365.4% | -5.0% | +439.8% | -0.0% | +1850.9% |
ADPT Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $52.44M(+10.5%) | $189.53M(+5.9%) |
| Dec 2024 | $178.96M(+5.1%) | $47.46M(+2.2%) | $178.96M(+0.9%) |
| Sep 2024 | - | $46.44M(+7.5%) | $177.28M(+5.0%) |
| Jun 2024 | - | $43.19M(+3.1%) | $168.77M(-3.3%) |
| Mar 2024 | - | $41.87M(-8.5%) | $174.50M(+2.5%) |
| Dec 2023 | $170.28M(-8.1%) | $45.78M(+20.7%) | $170.28M(-5.2%) |
| Sep 2023 | - | $37.92M(-22.5%) | $179.69M(-5.2%) |
| Jun 2023 | - | $48.93M(+30.0%) | $189.60M(+2.9%) |
| Mar 2023 | - | $37.65M(-31.8%) | $184.34M(-0.5%) |
| Dec 2022 | $185.31M(+20.1%) | $55.20M(+15.4%) | $185.31M(+10.3%) |
| Sep 2022 | - | $47.83M(+9.6%) | $168.04M(+5.2%) |
| Jun 2022 | - | $43.66M(+13.1%) | $159.68M(+3.3%) |
| Mar 2022 | - | $38.62M(+1.8%) | $154.52M(+0.1%) |
| Dec 2021 | $154.34M | $37.93M(-3.9%) | $154.34M(+5.3%) |
| Sep 2021 | - | $39.47M(+2.5%) | $146.60M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $38.51M(+0.2%) | $133.43M(+15.1%) |
| Mar 2021 | - | $38.44M(+27.4%) | $115.91M(+17.8%) |
| Dec 2020 | $98.38M(+15.6%) | $30.18M(+14.8%) | $98.38M(+6.5%) |
| Sep 2020 | - | $26.30M(+25.3%) | $92.41M(+0.3%) |
| Jun 2020 | - | $20.99M(+0.4%) | $92.17M(-1.2%) |
| Mar 2020 | - | $20.91M(-13.6%) | $93.31M(+9.7%) |
| Dec 2019 | $85.07M(+52.8%) | $24.21M(-7.1%) | $85.07M(+9.0%) |
| Sep 2019 | - | $26.06M(+17.7%) | $78.05M(+12.8%) |
| Jun 2019 | - | $22.14M(+74.8%) | $69.18M(+18.0%) |
| Mar 2019 | - | $12.67M(-26.3%) | $58.61M(+5.3%) |
| Dec 2018 | $55.66M(+44.8%) | $17.19M(+0.0%) | $55.66M(+44.7%) |
| Sep 2018 | - | $17.19M(+48.6%) | $38.47M(+80.8%) |
| Jun 2018 | - | $11.57M(+19.1%) | $21.28M(+119.1%) |
| Mar 2018 | - | $9.71M | $9.71M |
| Dec 2017 | $38.45M | - | - |
FAQ
- What is Adaptive Biotechnologies annual revenue?
- What is the all time high annual revenue for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual revenue year-on-year change?
- What is Adaptive Biotechnologies quarterly revenue?
- What is the all time high quarterly revenue for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly revenue year-on-year change?
- What is Adaptive Biotechnologies TTM revenue?
- What is the all time high TTM revenue for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM revenue year-on-year change?
What is Adaptive Biotechnologies annual revenue?
The current annual revenue of ADPT is $178.96M
What is the all time high annual revenue for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual revenue is $185.31M
What is Adaptive Biotechnologies annual revenue year-on-year change?
Over the past year, ADPT annual revenue has changed by +$8.68M (+5.10%)
What is Adaptive Biotechnologies quarterly revenue?
The current quarterly revenue of ADPT is $52.44M
What is the all time high quarterly revenue for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly revenue is $55.20M
What is Adaptive Biotechnologies quarterly revenue year-on-year change?
Over the past year, ADPT quarterly revenue has changed by +$10.57M (+25.24%)
What is Adaptive Biotechnologies TTM revenue?
The current TTM revenue of ADPT is $189.53M
What is the all time high TTM revenue for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM revenue is $189.60M
What is Adaptive Biotechnologies TTM revenue year-on-year change?
Over the past year, ADPT TTM revenue has changed by +$15.03M (+8.61%)